Menu

1 / 2

Viking Therapeutics, Inc. (VKTX) Q1 2026 Earnings Call Transcript

Seeking Alpha·SA Transcripts·6 months ago
#V1UG0n4s
#source#chevron#alpha#research#viking
Reading 0:00
15s threshold

Viking Therapeutics, Inc. ( VKTX ) Q1 2026 Earnings Call April 29, 2026 4:30 PM EDT

Company Participants

Brian Lian - President, CEO & Director

Gregory Zante - Chief Financial Officer

Neil Aubuchon - Chief Commercial Officer

Conference Call Participants

Stephanie Diaz - Vida Strategic Partners, Inc.

Steven Seedhouse - Cantor Fitzgerald & Co., Research Division

Nathanael Charoensook - Leerink Partners LLC, Research Division

Michael Ulz - Morgan Stanley, Research Division

Ryan Deschner - Raymond James & Associates, Inc., Research Division

Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division

Biren Amin - Piper Sandler & Co., Research Division

Jay Olson - Oppenheimer & Co. Inc., Research Division

Tsan-Yu Hsieh - William Blair & Company L.L.C., Research Division

Jiale Song - Jefferies LLC, Research Division

William Wood - B.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.